作者: C. Gabriel
DOI: 10.1111/VOXS.12227
关键词: Intensive care medicine 、 Immunology 、 Selection (genetic algorithm) 、 Haematopoiesis 、 Transplant patient 、 Immunohaematology 、 Product selection 、 Hematopoietic stem cell 、 Transplantation 、 Medicine 、 Stem cell
摘要: Improving transfusion safety is a one corner stone for continuous improvements in haematopoietic stem cell and solid-organ transplantation. In this setting, additional selection methods are applied to blood products ensure sophisticated practice support patients with high risk of bleeding as well chronic demand. Furthermore, product transplantation very similar if focused on the avoidance viral infections adverse immune reactions.